10th Eilat International Educational Course: Pharmacological Treatment of Epilepsy

back

ILAE Curriculum Learning Objectives addressed by this course

• 3.1.1 Identify the spectrum of action for antiepileptic drugs (L1)
• 3.1.2 Demonstrate knowledge of pharmacokinetics and pharmacodynamics (L1)
• 3.1.3 Demonstrate knowledge regarding the adverse effects of antiepileptic drugs (L1)
• 3.1.4 Demonstrate knowledge of appropriate monitoring of AES serum levels (L2)
• 3.1.5 Demonstrate knowledge about drug interactions (e.g. enzyme induction, etc.) for AED/AED and AED/concomitant medication
• 3.1.6 Demonstrate knowledge about treatment of psychiatric and cognitive comorbidities in children and adults (L3)
• 3.2.1 Recommend appropriate therapy according to seizure type (L1)
• 3.2.2 Recommend appropriate therapy according to epilepsy syndrome (L2)
• 3.2.3 Recommend individualized titrations of optimal dosing for patients including starting and discontinuing medication (L1)
• 3.2.4 Communicate information regarding the antiepileptic drug regimen (L1)
• 3.2.5 Recommend second- and third-line treatments as necessary (L2)
• 3.3.1 Define treatment strategies considering issues specific to pre-menopausal women (L2)
• 3.3.2 Define treatment strategies considering issues specific to neonates and very young children (L3)
• 3.3.3 Define treatment strategies considering issues specific to the elderly (L2)
• 3.3.4 Define treatment strategies considering issues specific to sexual function and dysfunction (L2)
• 3.3.5 Define treatment strategies considering genetic markers (L3)
• 3.3.6 Define treatment strategies for infectious causes of epilepsy and seizures (L1)
• 3.3.7 Define treatment strategies for immune mediated causes of epilepsy and seizures (L2)
• 3.4.1 Demonstrate knowledge about the risks and opportunities associated with drug discontinuation and methodologies for individualized implementation (L2)
• 3.5.1 Identify patients who are drug resistant according to the current ILAE definition (L1)